Latest 8-K filings

NYSE
Sysco Corporation announced its agreement to acquire JRD Unico, Inc. and Warehouse Realty, LLC, presenting to investors on August 12, 2026, detailing expected benefits and financial projections.
NASDAQ
Monopar Therapeutics announced second quarter 2026 financial results, highlighting the initiation of a rolling NDA submission for ALXN1840 for Wilson disease and providing business updates, alongside increased R&D expenses and a net loss.
NASDAQ
XCF Global announces initial renewable diesel sales to Tartan Oil LLC, a subsidiary of Pilot Travel Centers, potentially generating $12.86M-$13.86M monthly.
NASDAQ
Alkermes plc announced an amendment to its credit agreement, reducing interest rates on its term loan facilities.
OQB
Vertical Data Inc. has successfully closed a private placement, raising $4.12 million through the sale of common stock to accredited investors.
NASDAQ
Neonode Inc. reported a 20.4% decrease in revenue for the three months ended June 30, 2026, alongside an increased operating loss and cash burn.
NASDAQ
Embrace Change Acquisition Corp. has secured a 12-month extension to its business combination deadline, moving it to August 12, 2027, following shareholder approval.
NASDAQ
Synopsys, Inc. has reported a change in its executive leadership, with Janet Lee stepping down as General Counsel and Corporate Secretary.
AMEX
CleanCore Solutions, Inc. announced the pricing of its public offering of common stock and warrants, aiming to raise approximately $100 million to fund AI infrastructure development.
NASDAQ
Capstone Holding Corp. announced robust second-quarter 2026 results, featuring a 67% revenue surge and positive Stone Business Adjusted EBITDA, while reaffirming full-year guidance.
NYSE
The Home Depot announced its CEO, Edward P. Decker, will take a temporary medical leave, with Ann-Marie Campbell and Richard V. McPhail stepping in to oversee operations.
NASDAQ
Spruce Biosciences reported Q2 2026 results, highlighting progress towards a TA-ERT BLA submission in Q4 2026, initiation of the TrAnsform study, and a $5.5 million strategic investment from patient advocacy groups.
Adamas Trust, Inc. has entered into an underwriting agreement to sell $90 million in aggregate principal amount of 9.600% Senior Notes due 2031.
NASDAQ
Rimini Street, Inc. has appointed Keith C. Costello as Executive Vice President and Chief Operating Officer, effective August 17, 2026, bringing extensive experience in scaling global operations and enterprise software.
NASDAQ
Dyadic International announced its second-quarter 2026 financial results, highlighting progress in commercialization and partnerships, alongside an increased net loss and reduced cash reserves.
NASDAQ
LiveOne announced record Q1 Fiscal 2027 results, with revenue reaching $19.4 million and Adjusted EBITDA at $4.3 million, marking a significant year-over-year improvement.
NASDAQ
PodcastOne announced record first quarter fiscal 2027 revenue of $16.1 million and a 172% year-over-year increase in Adjusted EBITDA to $1.6 million.
AMEX
Kartoon Studios has secured a streaming deal with Amazon Prime Video for its animated series 'Hundred Acre Wood,' set to launch February 18, 2027.
NASDAQ
CID HoldCo, Inc. has received a notification from Nasdaq of its determination to delist the company's common stock due to failure to meet the minimum Market Value of Listed Securities requirement, though the company intends to appeal.
AMEX
Splash Beverage Group, Inc. announced its intention to change its corporate name to Endovia Health Sciences, Inc., effective August 24, 2026, signaling a strategic shift into the cannabinoid health sciences sector.
NASDAQ
Aprea Therapeutics reported Q2 2026 results, noting accelerated enrollment in its Phase 1 APR-1051 trial and early signs of clinical activity.
Beeline Holdings CEO Nicholas Liuzza has invested an additional $500,000 in the company, reinforcing confidence in its growth strategy and execution.
NASDAQ
NeOnc Technologies announced positive topline results from the Phase 2a portion of its NEO100-01 study, showing a significant improvement in progression-free survival for patients with recurrent IDH1-mutant glioma.
NASDAQ
Citius Oncology, Inc. has expanded its Board of Directors with the appointment of Jonathan Peri, Ph.D., J.D., an independent director with extensive experience in higher education, financial services, and corporate governance.
AMEX
flyExclusive, Inc. announced robust financial results for Q2 2026, showcasing significant revenue growth, improved gross profit margins, and a positive shift to Adjusted EBITDA, alongside a strengthened balance sheet.
ENvue Medical, Inc. has entered into a $50 million committed equity facility with an institutional investor to provide flexible capital for working capital and preferred stock redemption.
NASDAQ
Madrigal Pharmaceuticals announced the appointment of Dr. John C. Reed, a prominent biopharmaceutical research leader, to its Board of Directors, effective August 11, 2026.
NASDAQ
Century Therapeutics reported Q2 2026 results, highlighting progress on CNTY-813 for Type 1 Diabetes with a pre-IND meeting with the FDA and strong preclinical data, alongside advancing CNTY-308 for autoimmune diseases, supported by a cash runway into Q1 2029.
NYSE
Madison Square Garden Entertainment Corp. announced robust financial results for fiscal year 2026, with revenues up 13% to $1.1 billion and operating income up 16%.
NASDAQ
Keurig Dr Pepper Inc. announced the appointment of Aaron Alt as an independent director to its Board, effective August 14, 2026, increasing the Board's size to ten members.